Evaluation of the performance characteristics of 6 rapid HIV antibody tests

Clinical Infectious Diseases

Volumn 52, Issue 2, 2011, Pages 257-263

  Delaney, Kevin P ^a   Branson, Bernard M ^a   Uniyal, Apurva ^b   Phillips, Susan ^a   Candal, Debra ^a   Owen, S Michele ^a   Kerndt, Peter R ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b STD Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN M;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; FALSE NEGATIVE RESULT; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADULT; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; LOS ANGELES; MALE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIROLOGY;

EID: 79951823626     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq068     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. Update: HIV counseling and testing using rapid tests-United States, 1995. MMWR Morb Mortal Wkly Rep 1998;47:211-215.
2. Kassler WJ, Dillon BA, Haley C, Jones WK, Goldman A. On-site, rapid HIV testing with same-day results and counseling. AIDS 1997;11:1045-1051. (Pubitemid 27259528)
3. Branson BM. State of the art for diagnosis of HIV infection. Clin Infect Dis 2007;45: S221-S225. (Pubitemid 351417220)
4. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:329-332.
5. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings. MMWR Recomm Rep 2006;55:1-17.
6. Centers for Disease Control and Prevention. Racial/ethnic disparities in diagnoses of HIV/AIDS-33 states, 2001-2005. MMWR Morb Mortal Wkly Rep 2007;56:189-193.
7. Centers for Disease Control and Prevention. Rapid HIV testing in outreach and other community settings-United States, 2004-2006. MMWR Morb Mortal Wkly Rep 2007;56:1233-1237.
8. Centers for Disease Control and Prevention. Rapid HIV testing among racial/ethnic minority men at gay pride events-nine U. S. cities, 2004-2006. MMWR Morb Mortal Wkly Rep 2007;56:602-604.
9. Heffelfinger JD, Sullivan PS, Branson BM, et al. Advancing HIV prevention demonstration projects: new strategies for a changing epidemic. Public Health Rep 2008;123:5-15.
10. White DA, Scribner AN, Schulden JD, Branson BM, Heffelfinger JD. Results of a rapid HIV screening and diagnostic testing program in an urban emergency department. Ann Emerg Med 2009;54:56-64.
11. Branson BM. Point-of-care rapid tests for HIV antibodies. J Lab Meth 2003;27:288-295. (Pubitemid 36988430)
12. Louie B, Wong E, Klausner JD, et al. Assessment of rapid tests for detection of human Immunodeficiency virus-specific antibodies in recently infected individuals. J Clin Microbiol 2008;46:1494-1497. (Pubitemid 351563599)
13. Owen SM, Yang C, Spira T, et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008;46:1588-1595. (Pubitemid 351657199)
14. Stekler JD, Swenson PD, Coombs RW, et al. HIV testing in a highincidence population: is antibody testing alone good enough? Clin Infect Dis 2009;49:444-453.
15. Brown P, Merline JR, Levine D, Minces LR. Repeatedly false-negative rapid HIV test results in a patient with undiagnosed advanced AIDS. Ann Intern Med 2008;149:71-72. (Pubitemid 351931151)
16. O'Connell RJ, Merritt TM, Malia JA, et al. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2003;41:2153-2155. (Pubitemid 36576551)
17. O'Connell RJ, Agan BK, Anderson SA, Malia JA, Michael NL. Sensitivity of the Multispot HIV-1/HIV-2 rapid test using samples from human immunodeficiency virus type 1-positive individuals with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2006;44:1831-1833. (Pubitemid 43726276)
18. Association of Public Health Laboratories. Public health laboratory issues in brief: 2006 HIV diagnostics survey.Public Health Laboratory Issues in Brief 2007:1-8. http://www.aphl.org/aphlprograms/infectious/Documents/HIV-issue- brief-2007.pdf Accessed: 12 November 2010.
19. Clopper C, Pearson E. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404-413.
20. Patel P, Mackellar D, Simmons P, et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010;170:66-74.
21. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001;50:1-58.
22. Wesolowski LG, MacKellar DA, Facente SN, et al. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 2006;20:1661-1666. (Pubitemid 44162409)
23. Walensky RP, Arbelaez C, Reichmann WM, et al. Revising expectations from rapid HIV tests in the emergency department. Ann Intern Med 2008;149(3) ; 153-160.
24. Jafa K, Patel P, Mackellar DA, et al. Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS ONE 2007;2: e185.
25. Centers for Disease Control and Prevention. False-positive oral fluid rapid HIV tests-New York City, 2005-2008. MMWR Morb Mortal Wkly Rep 2008;57:660-665.
26. Rahangdale L, Sarnquist C, Feakins C, Nassos P, Haller B, Cohan D. Rapid HIV testing on labor and delivery: lessons from the field. J Acquir Immune Defic Syndr 2007;46:376-378. (Pubitemid 350287372)
27. Centers for Disease Control and Prevention. Notice to readers: protocols for confirmation of reactive rapid HIV tests. MMWR Morb Mortal Wkly Rep 2004;53:221-222.
28. Centers for Disease Control and Prevention. Quality assurance guidelines for testing using rapid HIV antibody tests waived under the clinical laboratory improvement amendments of 1988 http://www.cdc.gov/hiv/topics/testing/resources/ guidelines/qa-guide.htm Accessed 28 August 2010.
29. Kerndt PR, Dubrow R, Aynalem G, et al. Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I. AIDS Behav 2009;13:1037-1045.
30. Miller WC, Leone PA, McCoy S, Nguyen TQ, Williams DE, Pilcher CD. Targeted testing for acute HIV infection in North Carolina. AIDS 2009;27:835-843.
31. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005;352:1873-1883. (Pubitemid 40627813)
32. Pilcher C, Louie B, Keating S, et al. A clinical study of antigen/antibody rapid testing for acute HIV infection [abstract 992]. In: Program abstracts of the 16th Conference on Retroviruses and Opportunistic Infections (Montreal). Alexandria, VA: Foundation for Retrovirology and Human Health, 2009.
33. Owen M, Patel P, Wesolowski LG, et al. Evaluation of the Abbott ARCHITECT Ag/Ab Combo® assay, an antigen/antibody combination test: implications for US HIV testing programs [abstract 991]. In: Program abstracts of the 16th Conference on Retroviruses and Opportunistic Infections (Montreal). Alexandria, VA: Foundation for Retrovirology and Human Health, 2009.
34. Bourlet T, Pretis C, Pillet S, Lesenechal M, Piche J, Pozzetto B. Comparative evaluation of the VIDAS HIV DUO Ultra assay for combined detection of HIV-1 antigen antibodies to HIV. J Virol Methods 2005;127:165-167. (Pubitemid 40828194)
35. Ly TD, Ebel A, Faucher V, Fihman V, Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods 2007;143:86-94. (Pubitemid 46802829)
36. Bennett B, Branson BM, Delaney KP, et al. HIV testing algorithms a status report. Washington, DC: Association for Public Health Laboratories, 2009. http://www.aphl.org/aphlprograms/infectious/hiv/Pages/HIVStatusReport.aspx Accessed: 12 November 2010.
37. Delaney KP, Owen SM, Candal D, et al. Ability of conventional and rapid immunoassays to confirm results of the ARCHITECT® Ag/Ab Combo assay in a 2-test serologic algorithm. [abstract 997]. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections (Montreal). Alexandria, VA: Foundation for Retrovirology and Human Health, 2009.
38. Hadgu A, Dendukuri N, Hilden J. Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiolog 2005;16:604-612. (Pubitemid 41233613)
39. Stürenburg E, Junker R. Point-of-care testing in microbiology: the advantages and disadvantages of immunochromatographic test strips. Dtsch Arztebl Int 2009;106:48-54.
40. Centers for Disease Control and Prevention. FDA-approved rapid HIV antibody screening tests-purchasing details http://www.cdc.gov/hiv/topics/ testing/rapid/rt-purchasing.htm. Accessed: 12 November 2010.